Gene · 51744
Papers3,665
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,665
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Alternative splicing of CD244 restrains natural killer cells at the maternal-fetal interface. | Mucosal Immunol | 2026 | 42805341 | PubTator, text mining | PubMed |
| Dual targeting of CD244 and CD2 by a viral-immunoevasin-guided engineered CD48-Fc mutant for T- and NK-cell modulation. | Front Immunol | 2026 | 42746293 | PubTator, text mining | PubMed |
| Could the Immune Modulation of Invariant Natural Killer T Cell and the Expression of CD244 and CD196 on Natural Killer Cell Subtypes Impact the Treatment Outcomes of Acute Myeloid Leukemia Patients? | J Hematol | 2026 | 42730131 | PubTator, text mining | PubMed |
| Impact of Gestational Maternal SARS-CoV-2 Infection on Neonatal Inflammatory Biomarkers. | Am J Reprod Immunol | 2026 | 42640037 | PubTator, text mining | PubMed |
| Irradiated CD19 chimeric antigen receptor YTS cells retain antitumor activity and offer a scalable alternative to autologous CAR-T therapy. | Haematologica | 2026 | 42610426 | PubTator, text mining | PubMed |
| Exploring the Causal Role of Circulating Inflammatory Proteins in Multiple Sclerosis: A Mendelian Randomization Study and Druggability Analysis. | Curr Neurovasc Res | 2026 | 42517387 | PubTator, text mining | PubMed |
| Dual Regulatory Functions and Therapeutic Potential of CD48 in Tumor Immunity. | Oncol Res | 2026 | 42500566 | PubTator, text mining | PubMed |
| CD244 overexpression indicates NK cell dysfunction and tumor progression in diffuse large B-cell lymphoma. | Front Immunol | 2026 | 42483169 | PubTator, text mining | PubMed |
| Inflammatory Cytokines May Mediate the Causal Relationship between Metabolites and Primary Sclerosing Cholangitis: A Bidirectional Mediation Mendelian Randomization Study. | Curr Med Chem | 2026 | 42337887 | PubTator, text mining | PubMed |
| A blueberry-derived polysaccharide inhibits SARS-CoV-2 papain-like protease and exhibits broad-spectrum anti-coronavirus activity. | Nat Prod Res | 2026 | 42262732 | PubTator, text mining | PubMed |
| Huayu Wan enhances immune checkpoint inhibitor efficacy in triple-negative breast cancer by normalizing tumor vasculature and remodeling the tumor immune microenvironment. | Front Immunol | 2026 | 42238595 | PubTator, text mining | PubMed |
| Multiple sclerosis-associated HLA demarcates EBV-specific CD8+ T cells with an exhausted and brain residency phenotype. | iScience | 2026 | 42111195 | PubTator, text mining | PubMed |
| A multimodal atlas for immunotherapeutic targeting of AML surface heterogeneity. | iScience | 2026 | 41959675 | PubTator, text mining | PubMed |
| A cross-sectional examination of immune adaptations during pregnancy in the ECHO Cohort. | Front Immunol | 2026 | 41948337 | PubTator, text mining | PubMed |
| MSTN and TCF12 as Candidate Immunometabolic Signatures in Glioma-Associated Foam Cells: Insights from Integrated Multi-Omics Analysis. | Curr Issues Mol Biol | 2026 | 41899441 | PubTator, text mining | PubMed |
| Re-Tooling of γδ T Cells for Cancer Immunotherapy Using Advanced Manufacturing and Genetic Engineering. | Cells | 2026 | 41892285 | PubTator, text mining | PubMed |
| Blood donor biobank pipeline to collect genome-based samples for research. | Sci Rep | 2026 | 41888180 | PubTator, text mining | PubMed |
| EBV infection outcomes determined by monocyte and TREG-driven immune dynamics in an ex vivo pbmc model. | PLoS Pathog | 2026 | 41860926 | PubTator, text mining | PubMed |
| Acute-on-chronic liver failure and immune dysregulation: Systemic inflammation and immunoparesis paradox. | Hepatol Commun | 2026 | 41812001 | PubTator, text mining | PubMed |
| Differences in the expression profiles of m6A-related genes and the prognostic role in immunotherapy for lung adenocarcinoma patients. | Front Oncol | 2026 | 41809822 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51744/papers